Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone

Calcified Tissue International

Volumn 75, Issue 1, 2004, Pages 71-77

  Cheng, Y Y ^a   Huang, L ^a   Lee, K M ^a   Xu, J K ^b   Zheng, M H ^b   Kumta, S M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apoptosis; Bisphosphonates; Giant cell tumor of bone (GCT); Stromal cell

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; DNA FRAGMENT; LIPOCORTIN 5; PAMIDRONIC ACID; ZOLEDRONIC ACID;

APOPTOSIS; ARTICLE; BONE DESTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENCY; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN TISSUE; NICK END LABELING; OSTEOCLAST; OSTEOCLASTOMA; OSTEOLYSIS; PRIORITY JOURNAL; STROMA CELL;

EID: 3342969286     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0120-2     Document Type: Article

References (24)

1. Turcotte RE, Sim FH, Unni KK (1993) Giant cell tumour of the sacrum. Clin Orthop 291:215-221
2. Zheng MH, Robbins P, Xu J, Huang L, Wood DJ, Papadimitriou JM (2001) The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol 16:297-307
3. Wuelling M, Engels C, Jesse N, Werner M, Kaiser E, Delling G (2002) Histogenesis of giant cell tumors. Pathologe 23:332-339
4. Abe Y, Yonemura K, Nishida K, Takagi K (1994) Giant cell tumor of bone: analysis of proliferative cells by double-labeling immunohistochemistry with anti-proliferating cell nuclear antigen antibody and culture procedure. Nippon Seikeigeka Gakkai Zasshi 68:407-414
5. Robinson D, Einhorn TA (1994) Giant cell tumour of bone: a unique paradigm of stroma-hematopoietic cellular interactions. J Cell Biochem 55:330-303
6. Ghert MA, Rizzo M, Harrelson JM, Scully SP (2002) Giant-cell tumor of the appendicular skeleton. Clin Orthop 400:201-210
7. Masui F (1998) Giant cell tumor of bone: a clinicopathologic study of prognostic factors. Pathol Int 48:723-729
8. Rock MG (1990) Curettage of giant cell tumor of bone. Factors influencing local recurrences and metastasis. Chir Organi Mov 75(suppl 1):43-46
9. Boutou-Bredaki S, Agapios P, Papachristou G (2001) Prognosis of giant cell tumor of bone. Histopathological analysis of 15 cases and review of the literature. Adv Clin Path 53:71-78 Review
10. Bonecamp PM (1986) Two modes of action of bisphosphonate on osteoclastic resorption of mineralized matrix. J Bone Miner Res 1:27-39
11. Flanagan AM, Chambers TJ (1991) Inhibition of bone resorption by bisphosphonate: interactions between bisphosphonates, osteoclasts, and bone. Calcif Tissue Int 49:407-415
12. Rodan GA (1998) Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol 38:375-388
13. Rogers MJ, Watts DJ, Russell RG (1997) Overview of bisphosphonates. Cancer (Phila) 80:1652-1660
14. Lowik CW, van der Pluijm G, van der Wee-Pals LJ, van Treslong-De Groot HB, Bijvoet OL (1988) Migration and phenotypic transformation of osteoclast precursors into mature osteoclast the effect of bisphosphonate. J Bone Miner Res 3:85-192
15. Hughes DE, Wright KR, Uy HL (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487
16. Selander KS, Mönkkönen J, Karhukorpi, EK , Härkönen P, Hannuniemi R, Väänänen HK (1996) Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol Pharmacol 50:1127-1138
17. Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent posttranslational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13:581-589
18. Coxon FP, Benford HL, Russell RG, Rogers MJ (1998) Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs. Mol. Pharmacol 54:631-638
19. Shipman CM, Croucher PI, Russell RGG, Rogers MJ (1998) The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. Cancer Res 58:5294-5297
20. Virtanen SS, Vaananen HK, Harkonen PL, Lakkakorpi PT (2002) Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 62:2708-2714
21. Jurgen S, Vera E, Borna T, Joachim B, Winfried W, Frans van V (2001) The bisphosphoate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro. Anticancer Drugs 12:459
22. Clezardin P, Gligorov J, Delmas P (2000) Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis. Joint Bone Spine 67(1):22
23. Yasko AW (2002) Giant cell tumor of bone. Curr Oncol Rep 4:520-526
24. Cheng YY, Huang L, Lee KM, Lai FM, Tam JSK, Kumta SM (2003) Cytochemical and ultrastructural study of the osteoclast-like giant cells of GCT following bisphosphonate administration. Ultrastruct Pathol 27:385-391